Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a (original) (raw)

• Sherr, C. J. Cancer cell cycles. Science 274, 1672–1677 (1996).
  Article ADS CAS PubMed Google Scholar
• Hall, M. & Peters, G. Genetic alterations of cyclin, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res. 68, 68–108 (1996).
  Google Scholar
• Weinber, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995).
  Article Google Scholar
• Sherr, C. J. G1 phase progression cycling on cue. Cell 79, 551–555 (1994).
  Article CAS PubMed Google Scholar
• Hunter, T. & Pines, J. Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 79, 573–582 (1994).
  Article CAS PubMed Google Scholar
• Serrano, M., Hannon, G. J. & Beach, D. Anew regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993).
  Article ADS CAS PubMed Google Scholar
• Kamb, A. et al. Acell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436–440 (1994).
  Article ADS CAS PubMed Google Scholar
• Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994).
  Article ADS CAS PubMed Google Scholar
• Caldas, C. et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8, 27–32 (1994).
  Article CAS PubMed Google Scholar
• Hussussian, C. J. et al. Germline p16 mutations in familial melanoma. Nature Genet. 8, 15–21 (1994).
  Article CAS PubMed Google Scholar
• Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 23–26 (1994).
  Article CAS PubMed Google Scholar
• Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996).
  Article CAS PubMed Google Scholar
• Koh, J., Enders, G. H., Dynlacht, B. D. & Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506–510 (1995).
  Article ADS CAS PubMed Google Scholar
• Serrano, M., Gomez-Lahoz, E., DePinho, R. A., Beach, D. & Bar-Sagi, D. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267, 249–252 (1995).
  Article ADS CAS PubMed Google Scholar
• Yang, R., Gombart, A. F., Serrano, M. & Koeffler, H. P. Mutational effects on the p16INK4a tumor supressor protein. Cancer Res. 55, 2503–2506 (1995).
  CAS PubMed Google Scholar
• Ranade, K. et al. Mutations associated with familial melanoma impair p16INK4 function. Nature Genet. 10, 114–116 (1995).
  Article CAS PubMed Google Scholar
• Parry, D. & Peters, G. Temperature-sensitive mutants of p16_CDKN2_ associated with familial melanoma. Mol. Cell. Biol. 16, 3844–3852 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, B. & Peng, Z. Defective folding of mutant p16(INK4) proteins encoded by tumor-derived alleles. J. Biol. Chem. 271, 28734–28737 (1996).
  Article CAS PubMed Google Scholar
• Arap, W., Knudsen, E. S., Wang, J. Y., Cavenee, W. K. & Huang, H. J. Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma. Oncogene 14, 603–609 (1997).
  Article CAS PubMed Google Scholar
• Wolfel, T. et al. Ap16_INK4a_-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281–1284 (1995).
  Article ADS CAS PubMed Google Scholar
• Zuo, L. et al. Germline mutations in the p16_INK4a_ binding domain of CDK4 in familial melanoma. Nature Genet. 12, 97–99 (1996).
  Article ADS CAS PubMed Google Scholar
• Hannon, G. J. & Beach, D. p15_INK4B_ is a potential effector of TGF β-induced cell cycle arrest. Nature 371, 257–261 (1994).
  Article ADS CAS PubMed Google Scholar
• Hirai, H., Roussel, M. F., Kato, J. Y., Ashmun, R. A. & Sherr, C. J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672–2681 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Guan, K. L. et al. Isolation and characterization of p19_INK4d_, a p16-related inhibitor specific to CDK6 and CDK4. Mol. Biol. Cell 7, 57–70 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Xiong, Y., Zhang, H. & Beach, D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7, 1572–1583 (1993).
  Article CAS PubMed Google Scholar
• Li, Y., Nichols, M. A., Shay, J. W. & Xiong, Y. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res. 54, 6078–6082 (1994).
  CAS PubMed Google Scholar
• Parry, D., Bates, S., Mann, D. J. & Peters, G. Lack of cyclin D–Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J. 14, 503–511 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Lukas, J. et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503–506 (1995).
  Article ADS CAS PubMed Google Scholar
• Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J. & Pavletich, N. P. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A–Cdk2 complex. Nature 382, 325–331 (1996).
  Article ADS CAS PubMed Google Scholar
• De Bondt, H. L. et al. Crystal structure of cyclin-dependent kinase 2. Nature 363, 595–602 (1993).
  Article ADS CAS PubMed Google Scholar
• Knighton, D. R. et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407–413 (1991).
  Article ADS CAS PubMed Google Scholar
• Gorina, S. & Pavletich, N. P. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001–1005 (1996).
  Article ADS CAS PubMed Google Scholar
• Luh, F. Y. et al. Structure of the cyclin-dependent kinase inhibitor p19Ink4d. Nature 389, 999–1003 (1997).
  Article ADS CAS PubMed Google Scholar
• Byeon, I. et al. Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol. Cell 1, 421–431 (1998).
  Article CAS PubMed Google Scholar
• Venkataramani, R., Swaminathan, K. & Marmostein, R. Crystal structure of the CDK4/6 inhibitory protein p18_INK4c_ provides insights into ankyrin-like repeat structure/function and tumor-derived p16_INK4_ mutations. Nature Struct. Biol. 5, 74–81 (1998).
  Article CAS PubMed Google Scholar
• Jeffrey, P. D. et al. Mechanism of CDK activation revealed by the structure of cyclin A–CDK2 ocmplex. Nature 376, 313–320 (1995).
  Article ADS CAS PubMed Google Scholar
• Russo, A., Jeffrey, P. D. & Pavletich, N. P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nature Struct. Biol. 3, 696–700 (1996).
  Article CAS PubMed Google Scholar
• Coleman, K. G. et al. Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J. Biol. Chem. 272, 18869–18874 (1997).
  Article CAS PubMed Google Scholar
• Brotherton, D. H. et al. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell cycle inhibitor p19INK4d. Nature 395, 244–250 (1998).
  Article ADS CAS PubMed Google Scholar
• Zoller, M. J., Nelson, N. C. & Taylor, S. S. Affinity labeling of cAMP-dependent protein kinase with p-Fluorosulfonylbenzoyl adenosine. J. Biol. Chem. 256, 10837–10842 (1981).
  CAS PubMed Google Scholar
• Atherton-Fessler, S., Parker, L. L., Geahlen, R. L. & Piwnica-Worms, H. Mechanisms of p34cdc2 regualtion. Mol. Cell. Biol. 13, 1675–1685 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Fahraeus, R., Paramio, J. M., Ball, K. L., Lain, S. & Lane, D. P. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A. Curr. Biol. 6, 84–91 (1996).
  Article CAS PubMed Google Scholar
• Gerber, M. R., Farrell, A., Deshaies, R. J., Herskowitz, I. & Morgan, D. O. Cdc37 is required for association of the protein kinase Cdc28 with G1 and mitotic cyclins. Proc. Natl Acad. Sci. USA 92, 4651–4655 (1995).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Stepanova, L., Leng, X., Parker, S. B. & Harper, J. W. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev. 10, 1491–1502 (1996).
  Article CAS PubMed Google Scholar
• Reynisdottir, I., Polyak, K., Iavarone, A. & Massagué, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9, 1831–1845 (1995).
  Article CAS PubMed Google Scholar
• Meyerson, M. & Harlow, E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077–2086 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Collaborative Computational Project, Number4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
• Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991).
  Article PubMed Google Scholar
• Brunger, A. T. X-PLOR, a System for Crystallography and NMR(Yale Univ. Press, New Haven, CT, 1991).
  Google Scholar
• Kraulis, P. J. Molscript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946–950 (1991).
  Article Google Scholar
• Merrit, E. A. & Murphy, M. E. Raster3D Version 2.0: a program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869–873 (1994).
  Article Google Scholar